Which country is adagrasib developed and produced in?
Adagrasib is an anti-cancer drug developed by American biotechnology company Amgen. Amgen is an influential multinational company in the field of biopharmaceuticals, headquartered in California, USA. The company focuses on R&D and production in the fields of biotechnology and biomedicine and is committed to developing innovative treatment options to improve the quality of life of patients around the world.
Adagrasib was developed byAmgen's R&D team using advanced biotechnology and drug design methods. The drug targets the KRAS G12C mutant in tumor cells and inhibits the growth and spread of tumors by inhibiting the activity of this mutant. Its unique mechanism provides new treatment options for some patients with advanced cancer and brings new hope to the medical field.

AmgenAs a global biotechnology company, it has advanced R&D facilities and an extensive global market network. The R&D and production of adagrasib requires strict clinical trials and quality control to ensure its safety and effectiveness. This process often involves working with partners and regulatory agencies around the world to ensure that drugs meet international standards and are widely recognized and used.
With the continuous emergence of innovative drugs such as adagrasib, Amgenas a leading biopharmaceutical company, will continue to play an important role in the field of cancer treatment, provide more treatment options for patients around the world, and contribute to the advancement of medical science.
Adagrasib is not yet available in China, so patients cannot purchase it domestically and need to purchase adagrasib through overseas channels. The foreign original drug of adagrasib is mainly the original American drug, which is very expensive. The price is more than 180,000 yuan, which is simply unaffordable for ordinary families. Fortunately, foreign generic drugs have been on the market recently, mainly the Laos Lucius Adagrasibu generic drug. A box only costs about 4,000 to 5,000 yuan, and the ingredients of the original drug and the generic drug are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)